Lyrica Sales Data
| Rank 18 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Lyrica U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 18 | $624,774 | 2.82% | 2,031 | 1.10% |
| Q3 2013 | 18 ( 1) |
$607,643 | 6.13% | 2,009 | -6.03% |
| Q2 2013 | 19 | $572,526 | 3.53% | 2,138 | 3.09% |
| Q1 2013 | 19 (2) |
$553,016 | 8.10% | 2,074 | 0.29% |
| Q4 2012 | 21 | $511,571 | 2.36% | 2,068 | 2.17% |
| Q3 2012 | 21 (7) |
$499,777 | 9.94% | 2,024 | 2.12% |
| Q2 2012 | 28 | $454,575 | -0.78% | 1,982 | -0.45% |
| Q1 2012 | 28 (3) |
$458,171 | 6.04% | 1,991 | -2.02% |
| Q4 2011 | 31 ( 2) |
$432,070 | 1.23% | 2,032 | 1.25% |
| Q3 2011 | 29 | $426,822 | -2.94% | 2,007 | -2.10% |
| Q2 2011 | 29 (1) |
$439,764 | 0.72% | 2,050 | 0.74% |
| Q1 2011 | 30 | $436,615 | n/a | 2,035 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
